China SXT Pharmaceuticals Income Statement (2018-2025) | SXTC

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Income Statement	Mar2018	Sep2018	Mar2019	Sep2019	Mar2020	Sep2020	Mar2021	Sep2021	Mar2022	Sep2022	Mar2023	Sep2023	Mar2024	Sep2024	Mar2025	Sep2025
Operating items
Restructuring Costs					144.35B	296.01B	0.00B	0.00B			0.00B	164.08B
Operating Expenses					144.35B	296.01B	0.00B	0.00B			0.00B	164.08B
Additional items
EPS (Weighted Average and Diluted)							0.03B	0.02B	0.03B	0.02B	0.03B	0.01B	0.02B	0.03B	0.02B	0.03B
Shares Outstanding (Weighted Average)	0.00B		0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.01B
Shares Outstanding (Diluted Average)		0.02B	0.02B				0.00B	0.78B	0.00B	0.10B		0.50B